Optimizing and developing a scalable, chemically defined, animal component-free lentiviral vector production process in a fixed-bed bioreactor (2023)
Attributed to:
FUTURE TARGETED HEALTHCARE MANUFACTURING HUB
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.omtm.2023.06.011
Publication URI: http://dx.doi.org/10.1016/j.omtm.2023.06.011
Type: Journal Article/Review
Parent Publication: Molecular Therapy - Methods & Clinical Development